2023
1. KOÇ, Z.; SAĞLAM, Z.; ÖZCAN, P.; YAVAN, G.; YÜKSEK, H. Complicated Splenosis Mimicking Malignancy Demonstrated By F-18 FDG PET-CT Verified By Tc-99m Nanocolloid SPECT-CT. MOLECULAR ONCOLOGİC IMAGİNG, 2023, 3, 13-17. 0 + 0

2022
1. ÖZCAN, P.; KOÇ, Z.; YAVAN, G.; ERÇOLAK, V. F-18 FDG PET/CT Scan Maybe More Helpfull Instead of Ga-68 PSMA Scan in the Case of Ductal Variant Prostate Cancer. MOLECULAR ONCOLOGİC IMAGİNG, 2022, 2, 22-25. 0 + 0

2024
13. YAVAN, G.; ÖZCAN, P.; KOÇ, Z. Spinal cord metastasis detected by FDG PET/CT in a patient with non-Hodgkin’s lymphoma. MOLECULAR ONCOLOGİC İMAGİNG, 2024, 4, 17-19. 0 + 0

12. gümüş, a.; ÖZCAN, P.; KOÇ, Z.; süleymanoğlu, m.; YAVAN, G. Contribution of FDG PET/CT to Patient Management in Thorax and Mediastinum Masses in Patients with Known Extra-Thorax Malignancy. MOLECULAR ONCOLOGİC İMAGİNG, 2024, 4, 11-16. 50 + 0

2023
11. YAVAN, G.; gümüş, a.; süleymanoğlu, m.; ÖZCAN, P.; KOÇ, Z. Right Subclavian Artery Anomaly Which Causes Narrowing of the Esophagus and Eventually Causes -‘‘Dysphagia Lusoria’’, Shown on PET/CT. MOLECULAR ONCOLOGİC İMAGİNG, 2023, 3, 15-17. 0 + 0

10. ÖZCAN, P.; KOÇ, Z.; günay, e.; SAĞLAM, Z.; YAVAN, G. The Use and Advantage of E-PSMA: The EANM Standardized Reporting Guideline v1.0 in Different Prostate Cancer Patients . MOLECULAR ONCOLOGİC IMAGİNG, 2023, 3, 17-24. 0 + 0

9. YAVAN, G.; gümüş, a.; KOÇ, Z.; ÖZCAN, P. A Case of Intraabdominal Gossypiboma Detected in FDG PET/CT Examination. MOLECULAR ONCOLOGİC İMAGİNG, 2023, 3, 8-11. 0 + 0

8. gümüş, a.; YAVAN, G.; ÖZCAN, P.; KOÇ, Z. A Case of Thalassemia Intermedia with Extramedullary Hematopoiesis Finding on FDG-PET/CT. MOLECULAR ONCOLOGİC İMAGİNG, 2023, 3, 12-14. 0 + 0

7. YAVAN, G.; KOÇ, Z.; ÖZCAN, P.; SAYAR, H.; TÜRKMEN, A.; ÇELİK, A.; SEZER, E. F-18 FDG PET/CT in a Soft Tissue Tumor with Pericardial Metastasis. MOLECULAR ONCOLOGİC IMAGİNG, 2023, 3, 18-21. 80 + 0

2022
6. ÖZCAN, P.; KOÇ, Z.; YAVAN, G.; gümüş, a. A Rare Case of Alveolar Rhabdomyosarcoma with Pancreatic Metastases and Pancreatitis Detected on FDG PET-CT Imaging [en]. MOLECULAR ONCOLOGİC İMAGİNG, 2022, 2, 63-65. 0 + 0

5. KOÇ, Z.; ÖZCAN, P.; YAVAN, G.; SAĞLAM, Z. Additional SPECT/CT in Determination of Gastrointestinal Bleeding Site in Scintigraphy. MOLECULAR ONCOLOGİC İMAGİNG, 2022, 2, 56-59. 0 + 0

4. ÖZCAN, P.; YAVAN, G.; KOÇ, Z. Does PET-CT Contribute to Sitoreductive Surgery in Advanced Stage Colorectal Cancers? . MOLECULAR ONCOLOGİC IMAGİNG, 2022, 2, 66-73. 100 + 0

3. ÖZCAN, P.; KOÇ, Z.; ERÇOLAK, V.; SAĞLAM, Z.; YAVAN, G.; BOZLU, M.; TEK, M.; AKBAY, E. Ga-68 PSMA PET-CT in Initial StagingFirstLine Imaging of Prostate Cancer: The Clinical Impact of Oligometastatic Disease. MOLECULAR ONCOLOGİC IMAGİNG, 2022, 2, -. 35 + 0

2. ÖZCAN, P.; KOÇ, Z.; ERÇOLAK, V.; SAĞLAM, Z.; YAVAN, G.; BOZLU, M.; TEK, M.; AKBAY, E. Ga-68 PSMA PET-CT in Initial Staging First Line Imaging of Prostate Cancer: The Clinical Impact of Oligometastatic Disease. MOLECULAR ONCOLOGİC IMAGİNG, 2022, 2, 15-24. 35 + 0

2021
1. KOÇ, Z.; ÖZCAN, P.; ÖZGE, C.; YAVAN, G. Generalized Large Vessel Arteritis Determined by F-18 FDGPET/CT In APatient With Lung Mass. MOLECULAR ONCOLOGİC IMAGİNG, 2021, 1, 18-19. 0 + 0

2023
1. Yavan, G.; Özcan, P.; Koç, Z.; Gümüş, A.; Gökulu, Ş. FDG PET/CT findings in a case of peritoneal tuberculosis. MOLECULAR ONCOLOGİC İMAGİNG, 2023, 3, 13-16. 0 + 0

1. YAVAN, G.; KOÇ, Z.; ÖZCAN, P.; ESER, K.; YALDIZ, M., AKCİĞER KANSERLİ HASTALARDA F-18-FDG PET/BT İLE SAPTANAN PANKREATİK HİPERMETABOLİK LEZYONLARIN PATOLOJİK KORELASYONU. 36. Ulusal Nükleer Tıp Kongresi, 2024-05-08, 2024-05-12, Antalya, Türkiye, . 22

1. Türkiye Nükleer Tıp Derneği , Üye No: 1173, Türkiye, 2022-02-24-Devam ediyor.